Grace Therapeutics GRCE
NASDAQ GRCE
$1.91 -0.06 (-3.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Return on Sales [ROS] (2020 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Return on Sales [ROS] of -7953.57% in fiscal Q4 2022 (quarter ended Mar 31, 2022), down 5953.57 percentage points from -2000.00% a year earlier.

Analysis

Grace Therapeutics (GRCE) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For FY2021 (ended Mar 31, 2021), Grace Therapeutics reported Return on Sales [ROS] of -8377.04%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 24.35%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 37.86%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 20.57%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -133.21%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 28.37%
10 Grace Therapeutics 31.08 Mn -35.18 Mn - -11,288.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,288.65%
Mar 31, 2026 -2,181.16%
Dec 31, 2025 -1,423.84%
Sep 30, 2025 -1,470.35%
Jun 30, 2025 -1,514.71%
Mar 31, 2025 -1,729.89%
Dec 31, 2024 -2,916.54%
Sep 30, 2024 -2,654.40%
Jun 30, 2024 -2,111.91%
Mar 31, 2022 -7,953.57%
Mar 31, 2021 -2,000.00%
Dec 31, 2020 -2,424.69%
API Access

Grace Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY